Syndromic Multiplex Diagnostic Market, Global Outlook and Forecast 2022-2028

March 2022 | 105 pages | ID: S3C522AC41B2EN
Market Monitor Global

Abstracts

Most patients with infectious illness have certain symptoms and signs that are indicative of a disease but becomes difficult to identify the actual causing agent. These set of signs and symptoms are referred to as syndrome.

This report contains market size and forecasts of Syndromic Multiplex Diagnostic in Global, including the following market information:

Global Syndromic Multiplex Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Syndromic Multiplex Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gastrointestinal Syndromic Multiplex Diagnostic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Syndromic Multiplex Diagnostic include Abbott, Hologic, Bosch, Danaher, Johnson & Johnson, Danaher, Bio-Rad Laboratories, Luminex and bioM?rieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Syndromic Multiplex Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Syndromic Multiplex Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Syndromic Multiplex Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Gastrointestinal Syndromic Multiplex Diagnostic
• Central Nervous System Syndromic Multiplex Diagnostic
• Others

Global Syndromic Multiplex Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Syndromic Multiplex Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostics Laboratories
• Research Institutes
• Others

Global Syndromic Multiplex Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Syndromic Multiplex Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Syndromic Multiplex Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Syndromic Multiplex Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Hologic
• Bosch
• Danaher
• Johnson & Johnson
• Danaher
• Bio-Rad Laboratories
• Luminex
• bioM?rieux
• Qiagen
• Alveo Technologies
• Mesa Biotech
• Applied BioCode
• Akonni Biosystems
• Diagenode Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Syndromic Multiplex Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Syndromic Multiplex Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Syndromic Multiplex Diagnostic Market Size: 2021 VS 2028
2.2 Global Syndromic Multiplex Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Syndromic Multiplex Diagnostic Players in Global Market
3.2 Top Global Syndromic Multiplex Diagnostic Companies Ranked by Revenue
3.3 Global Syndromic Multiplex Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Syndromic Multiplex Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Syndromic Multiplex Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Syndromic Multiplex Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Syndromic Multiplex Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Syndromic Multiplex Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Syndromic Multiplex Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Gastrointestinal Syndromic Multiplex Diagnostic
  4.1.3 Central Nervous System Syndromic Multiplex Diagnostic
  4.1.4 Others
4.2 By Type - Global Syndromic Multiplex Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Syndromic Multiplex Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Syndromic Multiplex Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Syndromic Multiplex Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostics Laboratories
  5.1.4 Research Institutes
  5.1.5 Others
5.2 By Application - Global Syndromic Multiplex Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Syndromic Multiplex Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Syndromic Multiplex Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Syndromic Multiplex Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Syndromic Multiplex Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Syndromic Multiplex Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Syndromic Multiplex Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Syndromic Multiplex Diagnostic Revenue, 2017-2028
  6.3.2 US Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.3.3 Canada Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Syndromic Multiplex Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Syndromic Multiplex Diagnostic Revenue, 2017-2028
  6.4.2 Germany Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.4.3 France Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.4.5 Italy Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.4.6 Russia Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Syndromic Multiplex Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Syndromic Multiplex Diagnostic Revenue, 2017-2028
  6.5.2 China Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.5.3 Japan Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.5.6 India Syndromic Multiplex Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Syndromic Multiplex Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Syndromic Multiplex Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Syndromic Multiplex Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.7.3 Israel Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Syndromic Multiplex Diagnostic Market Size, 2017-2028
  6.7.5 UAE Syndromic Multiplex Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Syndromic Multiplex Diagnostic Major Product Offerings
  7.1.4 Abbott Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Hologic
  7.2.1 Hologic Corporate Summary
  7.2.2 Hologic Business Overview
  7.2.3 Hologic Syndromic Multiplex Diagnostic Major Product Offerings
  7.2.4 Hologic Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Hologic Key News
7.3 Bosch
  7.3.1 Bosch Corporate Summary
  7.3.2 Bosch Business Overview
  7.3.3 Bosch Syndromic Multiplex Diagnostic Major Product Offerings
  7.3.4 Bosch Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Bosch Key News
7.4 Danaher
  7.4.1 Danaher Corporate Summary
  7.4.2 Danaher Business Overview
  7.4.3 Danaher Syndromic Multiplex Diagnostic Major Product Offerings
  7.4.4 Danaher Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Danaher Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Syndromic Multiplex Diagnostic Major Product Offerings
  7.5.4 Johnson & Johnson Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Danaher
  7.6.1 Danaher Corporate Summary
  7.6.2 Danaher Business Overview
  7.6.3 Danaher Syndromic Multiplex Diagnostic Major Product Offerings
  7.6.4 Danaher Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 Danaher Key News
7.7 Bio-Rad Laboratories
  7.7.1 Bio-Rad Laboratories Corporate Summary
  7.7.2 Bio-Rad Laboratories Business Overview
  7.7.3 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Major Product Offerings
  7.7.4 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Bio-Rad Laboratories Key News
7.8 Luminex
  7.8.1 Luminex Corporate Summary
  7.8.2 Luminex Business Overview
  7.8.3 Luminex Syndromic Multiplex Diagnostic Major Product Offerings
  7.8.4 Luminex Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Luminex Key News
7.9 bioM?rieux
  7.9.1 bioM?rieux Corporate Summary
  7.9.2 bioM?rieux Business Overview
  7.9.3 bioM?rieux Syndromic Multiplex Diagnostic Major Product Offerings
  7.9.4 bioM?rieux Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 bioM?rieux Key News
7.10 Qiagen
  7.10.1 Qiagen Corporate Summary
  7.10.2 Qiagen Business Overview
  7.10.3 Qiagen Syndromic Multiplex Diagnostic Major Product Offerings
  7.10.4 Qiagen Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Qiagen Key News
7.11 Alveo Technologies
  7.11.1 Alveo Technologies Corporate Summary
  7.11.2 Alveo Technologies Business Overview
  7.11.3 Alveo Technologies Syndromic Multiplex Diagnostic Major Product Offerings
  7.11.4 Alveo Technologies Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Alveo Technologies Key News
7.12 Mesa Biotech
  7.12.1 Mesa Biotech Corporate Summary
  7.12.2 Mesa Biotech Business Overview
  7.12.3 Mesa Biotech Syndromic Multiplex Diagnostic Major Product Offerings
  7.12.4 Mesa Biotech Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.12.5 Mesa Biotech Key News
7.13 Applied BioCode
  7.13.1 Applied BioCode Corporate Summary
  7.13.2 Applied BioCode Business Overview
  7.13.3 Applied BioCode Syndromic Multiplex Diagnostic Major Product Offerings
  7.13.4 Applied BioCode Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.13.5 Applied BioCode Key News
7.14 Akonni Biosystems
  7.14.1 Akonni Biosystems Corporate Summary
  7.14.2 Akonni Biosystems Business Overview
  7.14.3 Akonni Biosystems Syndromic Multiplex Diagnostic Major Product Offerings
  7.14.4 Akonni Biosystems Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.14.5 Akonni Biosystems Key News
7.15 Diagenode Diagnostics
  7.15.1 Diagenode Diagnostics Corporate Summary
  7.15.2 Diagenode Diagnostics Business Overview
  7.15.3 Diagenode Diagnostics Syndromic Multiplex Diagnostic Major Product Offerings
  7.15.4 Diagenode Diagnostics Syndromic Multiplex Diagnostic Revenue in Global Market (2017-2022)
  7.15.5 Diagenode Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Syndromic Multiplex Diagnostic Market Opportunities & Trends in Global Market
Table 2. Syndromic Multiplex Diagnostic Market Drivers in Global Market
Table 3. Syndromic Multiplex Diagnostic Market Restraints in Global Market
Table 4. Key Players of Syndromic Multiplex Diagnostic in Global Market
Table 5. Top Syndromic Multiplex Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Syndromic Multiplex Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Syndromic Multiplex Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Syndromic Multiplex Diagnostic Product Type
Table 9. List of Global Tier 1 Syndromic Multiplex Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Syndromic Multiplex Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Syndromic Multiplex Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Syndromic Multiplex Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Syndromic Multiplex Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Syndromic Multiplex Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Syndromic Multiplex Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Syndromic Multiplex Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Syndromic Multiplex Diagnostic Product Offerings
Table 32. Abbott Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Hologic Corporate Summary
Table 34. Hologic Syndromic Multiplex Diagnostic Product Offerings
Table 35. Hologic Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Bosch Corporate Summary
Table 37. Bosch Syndromic Multiplex Diagnostic Product Offerings
Table 38. Bosch Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Danaher Corporate Summary
Table 40. Danaher Syndromic Multiplex Diagnostic Product Offerings
Table 41. Danaher Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Syndromic Multiplex Diagnostic Product Offerings
Table 44. Johnson & Johnson Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Danaher Corporate Summary
Table 46. Danaher Syndromic Multiplex Diagnostic Product Offerings
Table 47. Danaher Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Bio-Rad Laboratories Corporate Summary
Table 49. Bio-Rad Laboratories Syndromic Multiplex Diagnostic Product Offerings
Table 50. Bio-Rad Laboratories Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Luminex Corporate Summary
Table 52. Luminex Syndromic Multiplex Diagnostic Product Offerings
Table 53. Luminex Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. bioM?rieux Corporate Summary
Table 55. bioM?rieux Syndromic Multiplex Diagnostic Product Offerings
Table 56. bioM?rieux Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Syndromic Multiplex Diagnostic Product Offerings
Table 59. Qiagen Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Alveo Technologies Corporate Summary
Table 61. Alveo Technologies Syndromic Multiplex Diagnostic Product Offerings
Table 62. Alveo Technologies Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 63. Mesa Biotech Corporate Summary
Table 64. Mesa Biotech Syndromic Multiplex Diagnostic Product Offerings
Table 65. Mesa Biotech Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 66. Applied BioCode Corporate Summary
Table 67. Applied BioCode Syndromic Multiplex Diagnostic Product Offerings
Table 68. Applied BioCode Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 69. Akonni Biosystems Corporate Summary
Table 70. Akonni Biosystems Syndromic Multiplex Diagnostic Product Offerings
Table 71. Akonni Biosystems Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)
Table 72. Diagenode Diagnostics Corporate Summary
Table 73. Diagenode Diagnostics Syndromic Multiplex Diagnostic Product Offerings
Table 74. Diagenode Diagnostics Syndromic Multiplex Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Syndromic Multiplex Diagnostic Segment by Type in 2021
Figure 2. Syndromic Multiplex Diagnostic Segment by Application in 2021
Figure 3. Global Syndromic Multiplex Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Syndromic Multiplex Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Syndromic Multiplex Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Syndromic Multiplex Diagnostic Revenue in 2021
Figure 8. By Type - Global Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Syndromic Multiplex Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Syndromic Multiplex Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hologic Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bosch Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Danaher Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Danaher Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bio-Rad Laboratories Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Luminex Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. bioM?rieux Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Alveo Technologies Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Mesa Biotech Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Applied BioCode Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Akonni Biosystems Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Diagenode Diagnostics Syndromic Multiplex Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)